1. Home
  2. GAB vs VCEL Comparison

GAB vs VCEL Comparison

Compare GAB & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GAB
  • VCEL
  • Stock Information
  • Founded
  • GAB 1986
  • VCEL 1989
  • Country
  • GAB United States
  • VCEL United States
  • Employees
  • GAB N/A
  • VCEL N/A
  • Industry
  • GAB Investment Managers
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • GAB Finance
  • VCEL Health Care
  • Exchange
  • GAB Nasdaq
  • VCEL Nasdaq
  • Market Cap
  • GAB 1.8B
  • VCEL 2.1B
  • IPO Year
  • GAB N/A
  • VCEL 1997
  • Fundamental
  • Price
  • GAB $6.32
  • VCEL $31.42
  • Analyst Decision
  • GAB
  • VCEL Strong Buy
  • Analyst Count
  • GAB 0
  • VCEL 6
  • Target Price
  • GAB N/A
  • VCEL $61.50
  • AVG Volume (30 Days)
  • GAB 667.8K
  • VCEL 677.8K
  • Earning Date
  • GAB 01-01-0001
  • VCEL 11-06-2025
  • Dividend Yield
  • GAB 10.91%
  • VCEL N/A
  • EPS Growth
  • GAB N/A
  • VCEL 2045.40
  • EPS
  • GAB N/A
  • VCEL 0.13
  • Revenue
  • GAB N/A
  • VCEL $249,119,000.00
  • Revenue This Year
  • GAB N/A
  • VCEL $18.35
  • Revenue Next Year
  • GAB N/A
  • VCEL $22.47
  • P/E Ratio
  • GAB N/A
  • VCEL $234.59
  • Revenue Growth
  • GAB N/A
  • VCEL 16.13
  • 52 Week Low
  • GAB $4.56
  • VCEL $30.26
  • 52 Week High
  • GAB $5.88
  • VCEL $63.00
  • Technical
  • Relative Strength Index (RSI)
  • GAB 80.88
  • VCEL 36.46
  • Support Level
  • GAB $6.14
  • VCEL $30.26
  • Resistance Level
  • GAB $6.04
  • VCEL $33.92
  • Average True Range (ATR)
  • GAB 0.06
  • VCEL 1.52
  • MACD
  • GAB 0.02
  • VCEL -0.22
  • Stochastic Oscillator
  • GAB 99.09
  • VCEL 17.55

About GAB Gabelli Equity Trust Inc. (The)

Gabelli Equity Trust Inc is a non-diversified closed-end management investment company. Its primary investment objective is the long-term growth of capital with income as a secondary objective. The Fund invests at least its assets in equity securities under normal market conditions. Its equity portfolio includes common stock, preferred stock, convertible or exchangeable securities, and warrants and rights to purchase such securities selected by the Investment Adviser. The company invests in various sectors, of which Food & Beverage, Financial Services, Equipment and Supplies, Entertainment, Consumer Products, Health Care, Diversified Industrial, Business Services, Consumer Services and others.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: